DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Dr Reddys Share Price Live Updates: Dr. Reddys Stock Update

Economic Times 4 hrs ago·30 Oct 2026, 2:55 am

Dr. Reddys Laboratories is currently in the news as investors monitor the company closely. The stock is actively trading, and market participants are watching for any significant price movements or updates that might impact the company's valuation.

This situation is important for investors because stock volatility can signal shifting market sentiment or upcoming corporate developments. Keeping an eye on the trading volume and price action will help retail investors gauge the immediate interest in the stock.

What to watch next involves monitoring official company announcements and broader market trends. Any news regarding regulatory approvals, financial results, or sector-specific developments could drive the stock's direction in the coming sessions.